US

Impact investors have an opportunity to make the AI industry safer and reap sizeable returns in the process, panellists tell the Impact Investor Global Summit.

Harper Court Ventures Fund I will target pre-seed and seed-stage companies in sectors that include AI, quantum computing, life sciences and energy.

LPs in Zeal Capital's Fund II include Citi Impact Fund, M&T Bank, MassMutual, Wells Fargo, Zaffre Investments and Spelman College, as well as VCs Scott Sandell and Jason Green.

LPs include French corporates Groupe ADP and Valeo, and Spanish government investment organization Institut Català de Finances, PEI reported.

The fund’s strategic and impact-oriented LPs include big pharma names such as Pfizer, Bristol Myers Squibb, AARP and Alzheimer’s Research UK, which are excited by improved scientific understanding of dementia that promise to increase clinical trial successes.

Greycroft, Baroda Ventures and Mercato Partners posted significant gains in the MNTN offering, while Insight Venture Partners, Atomico and 11.2 Capital are among the big winners for Hinge.

The firm has invested in Coupang, Carvana, Databricks, Flipkart, Discord, Stripe and Wiz.

Besides Sequoia, LPs include Level Ventures, Cendana Capital, Vintage Investment Partners, Marktlink Capital, Spring Creek, Isomer Capital and Nexus Bay.

The new fund, which is 25% larger than its debut, is backed by Isomer Capital, Exor NV's Lingotto, Fondazione Compagnia di San Paolo, Grinnell College's Endowment, RSJ Investments and Aldea Ventures, Lunar says.

Fund III was anchored by Cendana Capital and includes commitments from Intact Ventures, Atacama Ventures, NVNG Investment Advisors and strategic investor Schreiber Foods.